PATENT CLAIM ANALYSIS

Application Number: 15957835
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["424", "197110"]

Abstract:
The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.

Claim (Index 46):
A method for reducing plasma cholesterol levels in an subject, comprising administering to the subject a therapeutically effective amount of an immunogen, wherein the immunogen comprises an antigenic PCSK9 peptide linked to an immunogenic carrier, and wherein the antigenic PCSK9 peptide consists of an amino acid sequence selected from the group consisting of SEQ ID NOs: 67-73.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.34146
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14508977', '15266812', '15118143', '14225258', '13152032']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7556381362065332
- 35 USC 102 Novelty (BERT): 0.6554969802893829
- Combined Prediction Score: 0.7456240206148181
- Mean Citation Score: 515.8078459999998
- Max Citation Score: 668.9936
- Similarity Product: 591.6166359724044

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test